Serological assessment is advisable before COVID-19 vaccination

[1]  S. Fafi-Kremer,et al.  Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses. , 2021, JAMA.

[2]  C. Chirouze,et al.  Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine , 2021, Vaccine.

[3]  S. Bobdey,et al.  The conundrum of two-dose interval of ChAdOx1 nCOV-19 corona virus vaccine: Way ahead , 2021, Medical Journal Armed Forces India.

[4]  A. Rather,et al.  Higher incidence of reported adverse events following immunisation (AEFI) after first dose of COVID-19 vaccine among previously infected health care workers , 2021, Medical Journal Armed Forces India.

[5]  G. Lippi,et al.  Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How? , 2021, Diagnostics.

[6]  M. Bhattacharya,et al.  The current second wave and COVID-19 vaccination status in India , 2021, Brain, Behavior, and Immunity.

[7]  G. Lippi,et al.  Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination , 2021, Diagnostics.

[8]  Belayneh Mengist,et al.  Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis , 2021, PloS one.

[9]  V. Simon,et al.  Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine , 2021, The New England journal of medicine.

[10]  J. Rassen,et al.  Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection , 2021, JAMA internal medicine.

[11]  Ravindra Rao,et al.  Treatment of substance use disorders through the government health facilities: Developments in the “Drug De-addiction Programme” of Ministry of Health and Family Welfare, Government of India , 2017, Indian journal of psychiatry.